Dr. Robin Duncan is an Associate Professor in the Department of Kinesiology (cross appointed to Biology), in the Faculty of Applied Health Sciences at the University of Waterloo. Dr. Duncan completed her PhD in Nutritional Sciences at the University of Toronto, where her research was focused on the molecular regulation of cholesterol biosynthesis in breast cancer. She then completed a Post-Doctoral Fellowship in the Department of Nutritional Science and Toxicology at the University of California at Berkeley, funded by The Canadian Institutes for Health Research, and the Natural Sciences and Engineering Research Council of Canada (NSERC).

There, her work centered on the characterization of new enzymes in lipid metabolism, with an emphasis on understanding the pathogenesis of Type 2 Diabetes Mellitus, and obesity. The Duncan Lab continues to work on the discovery and characterization of novel lipid metabolizing enzymes, and has additional interests in the role of bioactive lipids in health and disease, including both endogenously synthesized lipids, and bioactive nutraceuticals. Areas of expertise in disease research include diabetes, cancer, inherited mitochondrial disorders, and neurological disorders. The Duncan Lab is funded by NSERC, Diabetes Canada, Mitacs, the Barth Syndrome Foundation, the Canada Foundation for Innovation, and an Early Researcher Award from the Government of Ontario.